Meeting
2022 ASCO Annual Meeting
A randomized phase III clinical trial of acupuncture for chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors.
Authors
Andee Dooley
Memorial Sloan Kettering Cancer Center, New York, NY
Andee Dooley , Katherine Han , Wanqing Iris Zhi , Lauren Piulson , Christina Seluzicki , Ting Bao
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Late and Long-Term Adverse Effects
Clinical Trial Registration Number
NCT04917796
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr TPS12145)
DOI
10.1200/JCO.2022.40.16_suppl.TPS12145
Abstract #
TPS12145
Poster Bd #
385b
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
A randomized phase III clinical trial of yoga for chemotherapy-induced peripheral neuropathy treatment.
First Author: Katherine Han
Poster
2023 ASCO Annual Meeting
A randomized phase III clinical trial of acupuncture for chemotherapy-induced peripheral neuropathy in survivors of cancer.
First Author: Ivana Lopez-Nieves
Poster
2023 ASCO Annual Meeting
A randomized phase III clinical trial of yoga for chemotherapy-induced peripheral neuropathy treatment.
First Author: Kirin Saint
Poster
2024 ASCO Annual Meeting
Prospective evaluation of the effect of 3 days of post-chemotherapy dexamethasone on patient reported symptoms in gynecologic oncology patients treated with carboplatin and paclitaxel.
First Author: Hayley Hart